You are here: Industry Insights > Avid

News List

Avid Bioservices Appoints Esther M. Alegria to Board contractpharma
July 05, 2021
Avid Bioservices, Inc., a dedicated biologics CDMO, has appointed Esther M. Alegria, Ph.D., as an independent member of the company’s board of directors.
Avid Bioservices to Manufacture Zynlonta for ADC Therapeutics contractpharma
May 26, 2021
Avid Bioservices Inc., a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing development and manufacturing services to biotechnology and pharmaceutical companies, will serve as ...
Avid Bioservices Begins Phase 2 of Myford Mfg. Expansion contractpharma
February 23, 2021
Avid Bioservices, Inc., a biologics CDMO, initiated the second phase of expansion of manufacturing capacity at its Myford facility.
Avid, Humanigen Enter Lenzilumab Mfg. Agreement contractpharma
February 04, 2021
Avid Bioservices, Inc. and Humanigen, Inc. have entered into a manufacturing services agreement to expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development for COVID-19.
Avid Selected to Lead Process Development of IOV-3001 contractpharma
August 10, 2020
Will provide process development, pilot-batch manufacturing & CGMP manufacturing services for Iovance Biotherapeutics.
Avid Names Richard Hancock Interim President & CEO contractpharma
May 21, 2019
Industry veteran with over 30 years of operational and executive experience succeeds Roger Lias.